Mounjaro
  1. Home
  2. Mounjaro
  3. Mounjaro

Mounjaro

Mounjaro is a prescription dual GIP and GLP-1 receptor agonist containing tirzepatide that is used to improve glycemic control in adults with type 2 diabetes and, for certain formulations, to support chronic weight management. It is supplied as a sterile prefilled injection pen for convenient once-weekly subcutaneous administration. The long-acting formulation provides consistent and reliable metabolic management.

BUY NOW

Category

Mounjaro contains tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that helps regulate blood glucose and body weight by enhancing glucose-dependent insulin secretion, reducing glucagon release, slowing gastric emptying, and promoting satiety. The once-weekly injectable formulation offers sustained therapeutic activity through a prefilled injection pen available in multiple dosage strengths to support individualized treatment. Manufactured under stringent pharmaceutical quality standards, the sterile injection pen is engineered for precise subcutaneous administration and dependable clinical performance. Mounjaro should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Mounjaro
Active Ingredient Tirzepatide
Dosage Form Sterile Prefilled Injection Pen
Route of Administration Subcutaneous Injection
Dosing Frequency Once Weekly (As Prescribed)
Storage Refrigerate at 2°C–8°C before first use

Product Also Known As

Mounjaro, Tirzepatide Injection, Mounjaro Injection Pen, Tirzepatide Prefilled Pen, Weekly Tirzepatide Injection, GIP GLP-1 Receptor Agonist, Diabetes Injection Pen